RFFC vs. SBIO
RFFC (ALPS Active Equity Opportunity ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - RFFC is a Large Cap Blend Equities fund actively managed by SS&C, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. RFFC is actively managed, while SBIO is passively managed. Over the past 5 years, RFFC returned 12.38%/yr vs 2.68%/yr for SBIO. A 0.55 correlation means they provide meaningful diversification when combined. RFFC charges 0.48%/yr vs 0.50%/yr for SBIO.
Performance
RFFC vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RFFC achieves a 10.59% return, which is significantly higher than SBIO's -0.39% return.
RFFC
- 1D
- -0.47%
- 1M
- 3.42%
- YTD
- 10.59%
- 6M
- 10.88%
- 1Y
- 28.37%
- 3Y*
- 21.20%
- 5Y*
- 12.38%
- 10Y*
- —
SBIO
- 1D
- 1.41%
- 1M
- -7.56%
- YTD
- -0.39%
- 6M
- 3.05%
- 1Y
- 65.41%
- 3Y*
- 17.80%
- 5Y*
- 2.68%
- 10Y*
- 8.02%
RFFC vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RFFC ALPS Active Equity Opportunity ETF | 10.59% | 16.83% | 23.51% | 19.50% | -14.58% | 22.33% | 12.48% | 24.77% | -10.23% | 21.02% |
SBIO ALPS Medical Breakthroughs ETF | -0.39% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Correlation
The correlation between RFFC and SBIO is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.54 |
Correlation (All Time) Calculated using the full available price history since Jun 8, 2016 | 0.55 |
The correlation between RFFC and SBIO has been stable across timeframes, ranging from 0.47 to 0.55 - a consistent structural relationship.
RFFC vs. SBIO - Sectors Allocation Comparison
Sectors
RFFC
SBIO
Technology
-
Industrials
-
Healthcare
Financial Services
Consumer Cyclical
-
Communication Services
-
Energy
-
Consumer Defensive
-
Utilities
-
Basic Materials
-
Real Estate
-
Technology
RFFC
SBIO
-
Industrials
RFFC
SBIO
-
Healthcare
RFFC
SBIO
Financial Services
RFFC
SBIO
Consumer Cyclical
RFFC
SBIO
-
Communication Services
RFFC
SBIO
-
Energy
RFFC
SBIO
-
Consumer Defensive
RFFC
SBIO
-
Utilities
RFFC
SBIO
-
Basic Materials
RFFC
SBIO
-
Real Estate
RFFC
SBIO
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RFFC vs. SBIO — Risk / Return Rank
RFFC
SBIO
RFFC vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Active Equity Opportunity ETF (RFFC) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RFFC | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.13 | ||
| Sortino ratioReturn per unit of downside risk | +0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.36 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 3.08 | 5.19 | -2.11 |
| Martin ratioReturn relative to average drawdown | 14.17 | 15.57 | -1.39 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RFFC | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.38 | 2.24 | +0.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.77 | 0.08 | +0.68 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.24 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.71 | 0.21 | +0.50 |
Drawdowns
RFFC vs. SBIO - Drawdown Comparison
The maximum RFFC drawdown since its inception was -36.26%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for RFFC and SBIO.
Loading charts...
Drawdown Indicators
| RFFC | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.26% | -63.06% | +26.80% |
Max Drawdown (1Y)Largest decline over 1 year | -9.25% | -12.66% | +3.41% |
Max Drawdown (3Y)Largest decline over 3 years | -18.45% | -42.44% | +23.99% |
Max Drawdown (5Y)Largest decline over 5 years | -22.29% | -53.10% | +30.81% |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.06% | — |
Current DrawdownCurrent decline from peak | -0.54% | -16.79% | +16.25% |
Average DrawdownAverage peak-to-trough decline | -5.02% | -28.45% | +23.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.01% | 4.22% | -2.21% |
Volatility
RFFC vs. SBIO - Volatility Comparison
The current volatility for ALPS Active Equity Opportunity ETF (RFFC) is 3.00%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.48%. This indicates that RFFC experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RFFC | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.00% | 9.48% | -6.48% |
Volatility (6M)Calculated over the trailing 6-month period | 9.32% | 22.70% | -13.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 12.00% | 29.42% | -17.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.27% | 33.56% | -17.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.97% | 33.17% | -15.20% |
RFFC vs. SBIO - Expense Ratio Comparison
RFFC has a 0.48% expense ratio, which is lower than SBIO's 0.50% expense ratio.
Dividends
RFFC vs. SBIO - Dividend Comparison
RFFC's dividend yield for the trailing twelve months is around 0.72%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
RFFC ALPS Active Equity Opportunity ETF | 0.72% | 0.78% | 1.05% | 1.35% | 1.41% | 0.71% | 1.79% | 1.34% | 1.36% | 0.93% | 0.66% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% |
Frequently Asked Questions
RFFC and SBIO have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.48%) compared to RFFC (3.00%). In terms of maximum drawdown, RFFC dropped -36.26% vs SBIO's -63.06%.
On 5-year performance, RFFC leads with 12.38% vs 2.68% for SBIO. On fees, RFFC is cheaper at 0.48% per year. On volatility, RFFC has been the lower-risk option at 3.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, RFFC has performed better with a 12.38% return vs 2.68%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
RFFC is cheaper with a 0.48% expense ratio, compared with 0.50% for SBIO.
RFFC has the higher dividend yield at 0.72%, compared with 0.00% for SBIO.
RFFC is categorized as Large Cap Blend Equities, while SBIO is Health & Biotech Equities. Their fees differ too: 0.48% for RFFC and 0.50% for SBIO.
RFFC currently has the higher Sharpe Ratio (2.38 vs 2.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RFFC and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer